EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A cross-validated deep learning framework for automated detection of DMBA-induced ovarian cancer from histopathological images with CA-125 biomarker support

John Sushma Nannepaga, Kusuma Kandati, Munisankar Matam, Sai Lohitha Nayeneni, Megha Priya Adem

Frontiers in Artificial Intelligence · 01.07.2026 · 9

DOI: 10.3389/frai.2026.1851807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Artificial Intelligence, online erschienen am 01.07.2026. Verfasst von John Sushma Nannepaga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Sri Padmavati Mahila Visvavidyalayam, Tirupati, India. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) remains a major global health challenge due to its asymptomatic progression and the lack of reliable diagnostic tools. Recent advances in artificial intelligence (AI) offer promising opportunities to enhance diagnostic accuracy through automated analysis of biomedical images and integration of multimodal data. Female albino rats were divided into control and cancer–induced groups. OC were chemically induced by 7,12-Dimethylbenz[a]anthracene (DMBA) exposure. Blood samples were collected at baseline and predefined post-induction time points to quantify serum Cancer Antigen 125 (CA-125) levels, which were significantly elevated in the cancer group (438.7 ± 6.4 U/mL) compared with controls (22.5 ± 3.1 U/mL; p < 0.01). Ovarian tissues were harvested, processed, and imaged for high-resolution histopathological analysis. A custom convolutional neural network (CNN) was developed to classify ovarian tissue images into normal and cancerous categories. The dataset consisted of 904 labeled images and was evaluated using stratified data splitting and 5-fold cross-validation. The proposed CNN achieved a test accuracy of 96.69%, precision of 95.8%, recall of 97.2%, and F1-score of 96.5%. Cross-validation further demonstrated robust and stable performance with a mean accuracy of 96.42 ± 0.52%. Comparative benchmarking showed superior performance over conventional machine learning methods and transfer learning models, including Support Vector Machine, Random Forest, MobileNetV2, ResNet50, and EfficientNetB0. These findings indicate that the integration of serum biomarkers, histopathology, and deep learning provides a robust preclinical framework for ovarian cancer detection. This AI-assisted diagnostic strategy demonstrates strong translational potential for improving early diagnosis, risk stratification, and clinical decision support in ovarian cancer.

Schlagwörter

Stichwörter der Autor:innen

CA-125DMBA-induced rat modelartificial intelligenceconvolutional neural networksearly diagnosishistopathologyovarian cancer

Autor:innen und Institutionen

  • Department of Biotechnology, Sri Padmavati Mahila Visvavidyalayam, Tirupati, India.
  • Department of Electronics and Communication Engineering, Sri Padmavati Mahila Visvavidyalayam, Tirupati, India.
  • Department of Computer Science and Engineering, Sri Padmavati Mahila Visvavidyalayam, Tirupati, India.
  • PM- USHA, R&D Cell, Sri Padmavati Mahila Visvavidyalayam, Tirupati, India.

Zitieren

APA

Nannepaga, J. S., Kandati, K., Matam, M., Lohitha Nayeneni, S., & Priya Adem, M. (2026). A cross-validated deep learning framework for automated detection of DMBA-induced ovarian cancer from histopathological images with CA-125 biomarker support. Frontiers in Artificial Intelligence, 9. https://doi.org/10.3389/frai.2026.1851807

Vancouver

Nannepaga JS, Kandati K, Matam M, Lohitha Nayeneni S, Priya Adem M. A cross-validated deep learning framework for automated detection of DMBA-induced ovarian cancer from histopathological images with CA-125 biomarker support. Frontiers in Artificial Intelligence. 2026;9. doi:10.3389/frai.2026.1851807

BibTeX
@article{Nannepaga2026,
  author = {Nannepaga, John Sushma and Kandati, Kusuma and Matam, Munisankar and Lohitha Nayeneni, Sai and Priya Adem, Megha},
  title = {A cross-validated deep learning framework for automated detection of DMBA-induced ovarian cancer from histopathological images with CA-125 biomarker support},
  journal = {Frontiers in Artificial Intelligence},
  year = {2026},
  volume = {9},
  doi = {10.3389/frai.2026.1851807}
}
Kostenlos starten →